Iran Pharmaceutical Import Market Review, 2004-2008

Find Industry reports, Company profiles
ReportLinker and Market Statistics

>> Get this Report Now by email!

Iran Pharmaceutical Import Market Review, 2004-2008
Published on March 2010

Report Summary

Since 1999 when the private sector permitted to participate in importation, the import pharmaceutical market of Iran has experienced
a significant growth. Increasing importation has resulted in compound annual growth rate of 31% over four years (2005-2008) which
led it to reach the value of US$802 million in 2008 with value share of 35% of total pharmaceutical market. In addition to its growth
potential, the increasing need for specialist care (targeted treatment) and overall rising demand for health care and pharmaceutical
products has made Iran a highly attractive market for international firms in order to shape and develop the market for demanded
pharmaceuticals.

Analyzed in a five-year period (2004-2008), this report provides you with the latest detailed information available on the market of
imported pharmaceuticals and allows you to investigate trends in its different segments. Furthermore, it enables you to identify
opportunities and growth sectors interest your business and spot your competition within the market where over 100 international and
multinational companies selling their products.

The report's factual approach makes it an essential reference for decision makers in pharmaceutical companies that interested to
enter and expand their business in Iran's fast growing market and benefit from its lucrative opportunities.

This report presented in 17 chapters and categorized information in two standpoints:

1- Total import market review

In this section detailed historic information has been provided, some of which are import market size by anatomical main groups
classified based on Anatomical Therapeutic Chemical (ATC) Classification System, market top 10 classes in terms of value by
second, third and forth level of ATC, market main dosage forms, top 20 pharmaceutical molecules, top 20 products, top10
multinational corporations, top 10 import agencies and top 10 international brands.

2- Import market analysis by anatomical main groups of ATC

The report segments import market into 14 anatomical main groups of ATC, including:

1. Alimentary tract and metabolism
2. Blood and blood forming organs
3. Cardiovascular system
4. Dermatologicals
5. Genitourinary system and sex hormones
6. Systemic hormonal preparations (excluding sex hormones and insulins)
7. Anti-infectives for systemic use
8. Antineoplastic and immunomodulating agents
9. Musculoskeletal system
10. Nervous system
11. Antiparasitic products, insecticides and repellents
12. Respiratory system

Iran Pharmaceutical Import Market Review, 2004-2008 Page 1/11


13. Sensory organs
14. Various

For each of above groups, detailed historic information is provided some of which are main therapeutic groups, main dosage forms,
top 10 pharmaceutical molecules, top 10 products, and top 10 import agencies.

Please note:
' This report only includes finished product market and does not cover raw materials and intermediary market.
' This report excludes dietary supplement market.

Companies mentioned in the report

Multinational corporations:

- Sanofi-aventis
- Roche
- Bayer Group
- Pfizer
- Novartis
- Merck & Co., Inc.
- Merck KGaA
- GlaxoSmithKline
- Biotest
- Apotex

Domestic import agencies:

- Cobel Darou
- Akbarieh Co.
- Behestan Darou
- Shafayb Gostar
- Jahan Behbood
- KBC Company
- Kamal Darou
- Ahran Tejarat Co.
- Darou Pakhsh Trade Promotion Company
- Neda Mahya Pharmaceutical Trading Co.

Table of Content

Chapter 1. An overview of Iran pharmaceutical import market
- Import market at a glance
- Quick look to drug registration process
- Pricing policy for imported pharmaceuticals
- Subsidy paid on pharmaceuticals
- Opportunities and challenges
- Summary
- Pharmaceutical import market size



- Market of OTC and hospital products
- Registered and named-patient basis market size
- Market value by drug administration routes
- Market value by ATC anatomical main groups
- Market value growth by ATC anatomical main groups
- Top 10 therapeutic main groups
- Top 10 therapeutic/pharmacological subgroups
- Top 10 chemical/therapeutic/pharmacological subgroups
- Market main dosage forms
- Market size by dosage form groups
- Top 20 pharmaceutical molecules
- Top 20 pharmaceutical products

Chapter 2. Multinational key players in the market
- Summary
- Top 10 international brands
- Top 10 multinational corporations
- Sanofi-aventis
- Roche
- Bayer Group
- Pfizer
- Novartis
- Merck & Co., Inc.
- Merck KGaA
- GlaxoSmithKline
- Biotest
- Apotex

Chapter 3. Import key players in the market
- Summary
- Top 10 import agencies
- Sales history of top 10 import agencies of 2008
- Top 10 import agencies profile
- Cobel Darou
- Akbarieh Co.
- Behestan Darou
- Shafayb Gostar
- Jahan Behbood
- KBC Company
- Kamal Darou
- Ahran Tejarat Co.
- Darou Pakhsh Trade Promotion Company
- Neda Mahya Pharmaceutical Trading Co.

Chapter 4. Therapy area analysis: Alimentary tract and metabolism
- Summary
- Therapeutic main groups
- Main dosage forms




Chapter 5.Therapy area analysis: Blood and blood forming organs
- Summary
- Main dosage forms

Chapter 6. Therapy area analysis: Cardiovascular system
- Summary
- Main dosage forms

Chapter 7. Therapy area analysis: Dermatologicals
- Summary
- Main dosage forms

Chapter 8. Therapy area analysis: Genitourinary system and sex hormones
- Summary
- Main dosage forms

Chapter 9. Therapy area analysis: Systemic hormonal preparations
- Summary
- Main dosage forms

Chapter 10. Therapy area analysis: Anti-infectives for systemic use
- Summary
- Main dosage forms



Chapter 11. Therapy area analysis: Antineoplastic and immunomodulating agents
- Summary
- Main dosage forms

Chapter 12. Therapy area analysis: Musculoskeletal system
- Summary
- Main dosage forms

Chapter 13. Therapy area analysis: Nervous system
- Summary
- Main dosage forms

Chapter 14. Therapy area analysis: Antiparasitic products, insecticides and repellents
- Summary
- Main dosage forms

Chapter 15. Therapy area analysis: Respiratory system
- Summary
- Main dosage forms

Chapter 16. Therapy area analysis: Sensory organs
- Summary
- Main dosage forms

Chapter 17. Therapy area analysis: Various
- Summary



- Main subgroups
- Main dosage forms

List of tables

Table 1.1. Iran pharmaceutical import market value and volume, 2004-2008
Table 1.2. Hospital and OTC drugs import market size, 2008
Table 1.3. Registered and named-patient basis import market value, 2004-2008
Table 1.4. Pharmaceutical import market by routes of administration of drugs, 2004-2008
Table 1.5. Import market size by first level of ATC code (anatomical main groups), 2004-2008
Table 1.6. Import market value annual % change by first level of ATC code (anatomical main groups), 2004-2008
Table 1.7. Import market top 10 by second level of ATC code (therapeutic main groups), 2004-2008
Table 1.8. Import market top 10 by third level of ATC code (therapeutic/pharmacological subgroups), 2004-2008
Table 1.9. Import market top 10 by fourth level of ATC code (chemical/therapeutic/pharmacological subgroups), 2004-2008
Table 1.10. Value and volume of imported main dosage forms, 2004-2008
Table 1.11. Top 20 imported pharmaceutical molecules by value, 2004-2008
Table 1.12. Top 20 imported pharmaceutical products by value, 2004-2008
Table 2.1. Top 10 international brands by market sales value, 2005-2008
Table 2.2. Top 10 multinational/international corporations by market sales value, 2005-2008
Table 2.3. Sanofi-aventis market sales value, 2005-2008
Table 2.4. Roche market sales value, 2005-2008
Table 2.5. Bayer group market sales value, 2005-2008
Table 2.6. Pfizer market sales value, 2005-2008
Table 2.7. Novartis market sales value, 2005-2008
Table 2.8. Merck & Co. market sales value, 2005-2008
Table 2.9. Merck KGaA market sales value, 2005-2008
Table 2.10. GlaxoSmithKline market sales value, 2005-2008
Table 2.11. Biotest market sales value, 2005-2008
Table 2.12. Apotex market sales value, 2005-2008
Table 3.1. Top 10 importers by market sales value, 2004-2008
Table 3.2. Top 10 importers of 2008, five year trend in market sales value, 2004-2008
Table 3.3. Cobel Darou market sales value, 2005-2008
Table 3.4. Cobel Darou market sales value by first level of ATC code (anatomical main groups), 2005-2008
Table 3.5. Value and volume of main dosage forms sold by Cobel Darou, 2005-2008
Table 3.6. Akbarieh Co. market sales value, 2004-2008
Table 3.7. Akbarieh Co. market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.8. Value and volume of main dosage forms sold by Akbarieh Co., 2004-2008
Table 3.9. Behestan Darou market sales value, 2004-2008
Table 3.10. Behestan Darou market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.11. Value and volume of main dosage forms sold by Behestan Darou, 2004-2008
Table 3.12. Shafayb Gostar market sales value, 2004-2008
Table 3.13. Shafayb Gostar market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.14. Value and volume of main dosage forms sold by Shafayb Gostar, 2004-2008
Table 3.15. Jahan Behbood market sales value, 2004-2008
Table 3.16. Jahan Behbood market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.17. Value and volume of main dosage forms sold by Jahan Behbood, 2004-2008



Table 3.18. KBC Co. market sales value, 2005-2008
Table 3.19. KBC Co. market sales value by first level of ATC code (anatomical main groups), 2005-2008
Table 3.20. Value and volume of main dosage forms sold by KBC Co., 2005-2008
Table 3.21. Kamal Darou market sales value, 2004-2008
Table 3.22. Kamal Darou market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.23. Value and volume of main dosage forms sold by Kamal Darou, 2004-2008
Table 3.24. Ahran Tejarat Co. market sales value, 2004-2008
Table 3.25. Ahran Tejarat Co. market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.26. Value and volume of main dosage forms sold by Ahran Tejarat Co., 2004-2008
Table 3.27. Darou Pakhsh Trade Promotion Company market sales value, 2004-2008
Table 3.28. Darou Pakhsh Trade Promotion Co. market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.29. Value and volume of main dosage forms sold by Darou Pakhsh Trade Promotion Co., 2004-2008
Table 3.30. Neda Mahya Pharmaceutical Trading Co. market sales value, 2004-2008
Table 3.31. Neda Mahya Co. market sales value by first level of ATC code (anatomical main groups), 2004-2008
Table 3.32. Value and volume of main dosage forms sold by Neda Mahya Co., 2004-2008
Table 4.1. Import market value of pharmaceuticals for Alimentary tract & metabolism, 2004-2008
Table 4.2. Import market value of pharmaceuticals for Alimentary tract & metabolism by second level of ATC code (therapeutic main
groups), 2004-2008
Table 4.3. Import market by main dosage forms of pharmaceuticals for Alimentary tract & metabolism, 2004-2008
Table 4.4. Top 10 imported pharmaceutical molecules for Alimentary tract & metabolism, 2004-2008
Table 4.5. Top 10 imported pharmaceutical products for Alimentary tract & metabolism, 2004-2008
Table 4.6. Top 10 importers of pharmaceuticals for Alimentary tract & metabolism, 2004-2008
Table 5.1. Import market value of pharmaceuticals for Blood & blood forming organs, 2004-2008
Table 5.2. Import market value of pharmaceuticals for Blood & blood forming organs by second level of ATC code (therapeutic main
groups), 2004-2008
Table 5.3. Import market by main dosage forms of pharmaceuticals for Blood & blood forming organs, 2004-2008
Table 5.4. Top 10 imported pharmaceutical molecules for Blood & blood forming organs, 2004-2008
Table 5.5. Top 10 imported pharmaceutical products for Blood & blood forming organs, 2004-2008
Table 5.6. Top 10 importers of pharmaceuticals for Blood & blood forming organs, 2004-2008
Table 6.1. Import market value of pharmaceuticals for Cardiovascular system, 2004-2008
Table 6.2. Import market value of pharmaceuticals for Cardiovascular system by second level of ATC code (therapeutic main
groups), 2004-2008
Table 6.3. Import market by main dosage forms of pharmaceuticals for Cardiovascular system, 2004-2008
Table 6.4. Top 10 imported pharmaceutical molecules for Cardiovascular system, 2004-2008
Table 6.5. Top 10 imported pharmaceutical products for Cardiovascular system, 2004-2008
Table 6.6. Top 10 importers of pharmaceuticals for Cardiovascular system, 2004-2008
Table 7.1. Import market value of Dermatologicals, 2004-2008
Table 7.2. Import market value of Dermatologicals by second level of ATC code (therapeutic main groups), 2004-2008
Table 7.3. Import market by main dosage forms of Dermatologicals, 2004-2008
Table 7.4. Top 10 imported pharmaceutical molecules of Dermatologicals, 2004-2008
Table 7.5. Top 10 imported pharmaceutical products of Dermatologicals, 2004-2008
Table 7.6. Top 10 importers of Dermatologicals, 2004-2008
Table 8.1. Import market value of pharmaceuticals for Genitourinary system & sex hormones, 2004-2008
Table 8.2. Import market value of pharmaceuticals for Genitourinary system & sex hormones by second level of ATC code
(therapeutic main groups), 2004-2008
Table 8.3. Import market by main dosage forms of pharmaceuticals for Genitourinary system & sex hormones, 2004-2008
Table 8.4. Top 10 imported pharmaceutical molecules for Genitourinary system & sex hormones, 2004-2008
Table 8.5. Top 10 imported pharmaceutical products for Genitourinary system & sex hormones, 2004-2008
Table 8.6. Top 10 importers of pharmaceuticals for Genitourinary system & sex hormones, 2004-2008
Table 9.1. Import market value of Systemic hormonal preparations, 2004-2008



Table 9.2. Import market value of Systemic hormonal preparations by second level of ATC code (therapeutic main groups),
2004-2008
Table 9.3. Import market by main dosage forms of Systemic hormonal preparations, 2004-2008
Table 9.4. Top 10 imported pharmaceutical molecules of Systemic hormonal preparations, 2004-2008
Table 9.5. Top 10 imported pharmaceutical products of Systemic hormonal preparations, 2004-2008
Table 9.6. Top 10 importers of Systemic hormonal preparations, 2004-2008
Table 10.1. Import market value of Anti-infectives for systemic use, 2004-2008
Table 10.2. Import market value of Anti-infectives for systemic use by second level of ATC code (therapeutic main groups),
2004-2008
Table 10.3. Import market by main dosage forms of Anti-infectives for systemic use, 2004-2008
Table 10.4. Top 10 imported pharmaceutical molecules of Anti-infectives for systemic use, 2004-2008
Table 10.5. Top 10 imported pharmaceutical products of Anti-infectives for systemic use, 2004-2008
Table 10.6. Top 10 importers of Anti-infectives for systemic use, 2004-2008
Table 11.1. Import market value of Antineoplastic & immunomodulating agents, 2004-2008
Table 11.2. Import market value of Antineoplastic & immunomodulating agents by second level of ATC code
(therapeutic main groups), 2004-2008
Table 11.3. Import market by main dosage forms of Antineoplastic & immunomodulating agents, 2004-2008
Table 11.4. Top 10 imported pharmaceutical molecules of Antineoplastic & immunomodulating agents, 2004-2008
Table 11.5. Top 10 imported pharmaceutical products of Antineoplastic & immunomodulating agents, 2004-2008
Table 11.6. Top 10 importers of Antineoplastic & immunomodulating agents, 2004-2008
Table 12.1. Import market value of pharmaceuticals for Musculoskeletal system, 2004-2008
Table 12.2. Import market value of pharmaceuticals for Musculoskeletal system by second level of ATC code (therapeutic main
groups), 2004-2008
Table 12.3. Import market by main dosage forms of pharmaceuticals for Musculoskeletal system, 2004-2008
Table 12.4. Top 10 imported pharmaceutical molecules for Musculoskeletal system, 2004-2008
Table 12.5. Top 10 imported pharmaceutical products for Musculoskeletal system, 2004-2008
Table 12.6. Top 10 importers of pharmaceuticals for Musculoskeletal system, 2004-2008
Table 13.1. Import market value of pharmaceuticals for Nervous system, 2004-2008
Table 13.2. Import market value of pharmaceuticals for Nervous system by second level of ATC code (therapeutic main groups),
2004-2008
Table 13.3. Import market by main dosage forms of pharmaceuticals for Nervous system, 2004-2008
Table 13.4. Top 10 imported pharmaceutical molecules for Nervous system, 2004-2008
Table 13.5. Top 10 imported pharmaceutical products for Nervous system, 2004-2008
Table 13.6. Top 10 importers of pharmaceuticals for Nervous system, 2004-2008
Table 14.1. Import market value of Antiparasitics, insecticides & repellents, 2004-2008
Table 14.2. Import market value of Antiparasitics, insecticides & repellents by second level of ATC code (therapeutic main groups),
2004-2008
Table 14.3. Import market by main dosage forms of Antiparasitics, insecticides & repellents, 2004-2008
Table 14.4. Top 3 imported pharmaceutical molecules of Antiparasitics, insecticides & repellents, 2004-2008
Table 14.5. Top 3 imported pharmaceutical products of Antiparasitics, insecticides & repellents, 2004-2008
Table 14.6. Top 3 importers of Antiparasitics, insecticides & repellents, 2004-2008
Table 15.1. Import market value of pharmaceuticals for Respiratory system, 2004-2008
Table 15.2. Import market value of pharmaceuticals for Respiratory system by second level of ATC code (therapeutic main groups),
2004-2008
Table 15.3. Import market by main dosage forms of pharmaceuticals for Respiratory system, 2004-2008
Table 15.4. Top 10 imported pharmaceutical molecules for Respiratory system, 2004-2008
Table 15.5. Top 10 imported pharmaceutical products for Respiratory system, 2004-2008
Table 15.6. Top 10 importers of pharmaceuticals for Respiratory system, 2004-2008
Table 16.1. Import market value of pharmaceuticals for Sensory organs, 2004-2008
Table 16.2. Import market value of pharmaceuticals for Sensory organs by second level of ATC code (therapeutic main groups),



2004-2008
Table 16.3. Import market by main dosage forms of pharmaceuticals for Sensory organs, 2004-2008
Table 16.4. Top 10 imported pharmaceutical molecules for Sensory organs, 2004-2008
Table 16.5. Top 10 imported pharmaceutical products for Sensory organs, 2004-2008
Table 16.6. Top 5 importers of pharmaceuticals for Sensory organs, 2004-2008
Table 17.1. Various category import market value, 2004-2008
Table 17.2. Various category import market value by second level of ATC code (therapeutic main groups), 2004-2008
Table 17.3. Import market by main dosage forms of pharmaceuticals belong to Various category, 2004-2008
Table 17.4. Top 10 imported pharmaceutical molecules of Various category, 2004-2008
Table 17.5. Top 10 imported pharmaceutical products of Various category, 2004-2008
Table 17.6. Top 10 importers of pharmaceutical products for Various category, 2004-2008



Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.

Iran Pharmaceutical Import Market Review, 2004-2008

Product Formats
Please select the product formats and the quantity you require.

Digital Copy--USD 3 710.72 Quantity: _____

Hard Copy--USD 3 966.72 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________



Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Iran Pharmaceutical Import Market Review, 2004-2008

Recommended

Recommended

More Related Content

More from ReportLinker.com

More from ReportLinker.com (20)

Recently uploaded

Recently uploaded (20)

Iran Pharmaceutical Import Market Review, 2004-2008